170 related articles for article (PubMed ID: 23525827)
1. Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts.
Zeng Z; Zhang C; Chen J
J Bone Miner Metab; 2013 Jul; 31(4):409-16. PubMed ID: 23525827
[TBL] [Abstract][Full Text] [Related]
2. The dendritic cell-specific transmembrane protein DC-STAMP is essential for osteoclast fusion and osteoclast bone-resorbing activity.
Miyamoto T
Mod Rheumatol; 2006; 16(6):341-2. PubMed ID: 17164993
[TBL] [Abstract][Full Text] [Related]
3. Studies of OC-STAMP in Osteoclast Fusion: A New Knockout Mouse Model, Rescue of Cell Fusion, and Transmembrane Topology.
Witwicka H; Hwang SY; Reyes-Gutierrez P; Jia H; Odgren PE; Donahue LR; Birnbaum MJ; Odgren PR
PLoS One; 2015; 10(6):e0128275. PubMed ID: 26042409
[TBL] [Abstract][Full Text] [Related]
4. DC-STAMP Is an Osteoclast Fusogen Engaged in Periodontal Bone Resorption.
Wisitrasameewong W; Kajiya M; Movila A; Rittling S; Ishii T; Suzuki M; Matsuda S; Mazda Y; Torruella MR; Azuma MM; Egashira K; Freire MO; Sasaki H; Wang CY; Han X; Taubman MA; Kawai T
J Dent Res; 2017 Jun; 96(6):685-693. PubMed ID: 28199142
[TBL] [Abstract][Full Text] [Related]
5. DC-STAMP, the key fusion-mediating molecule in osteoclastogenesis.
Zhang C; Dou CE; Xu J; Dong S
J Cell Physiol; 2014 Oct; 229(10):1330-5. PubMed ID: 24420845
[TBL] [Abstract][Full Text] [Related]
6. Regulators of osteoclast differentiation and cell-cell fusion.
Miyamoto T
Keio J Med; 2011; 60(4):101-5. PubMed ID: 22200633
[TBL] [Abstract][Full Text] [Related]
7. Fusion Potential of Human Osteoclasts In Vitro Reflects Age, Menopause, and In Vivo Bone Resorption Levels of Their Donors-A Possible Involvement of DC-STAMP.
Møller AMJ; Delaissé JM; Olesen JB; Canto LM; Rogatto SR; Madsen JS; Søe K
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887359
[TBL] [Abstract][Full Text] [Related]
8. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells.
Yagi M; Miyamoto T; Sawatani Y; Iwamoto K; Hosogane N; Fujita N; Morita K; Ninomiya K; Suzuki T; Miyamoto K; Oike Y; Takeya M; Toyama Y; Suda T
J Exp Med; 2005 Aug; 202(3):345-51. PubMed ID: 16061724
[TBL] [Abstract][Full Text] [Related]
9. RANKL induces heterogeneous DC-STAMP(lo) and DC-STAMP(hi) osteoclast precursors of which the DC-STAMP(lo) precursors are the master fusogens.
Mensah KA; Ritchlin CT; Schwarz EM
J Cell Physiol; 2010 Apr; 223(1):76-83. PubMed ID: 20039274
[TBL] [Abstract][Full Text] [Related]
10. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
[TBL] [Abstract][Full Text] [Related]
11. MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation.
Dou C; Zhang C; Kang F; Yang X; Jiang H; Bai Y; Xiang J; Xu J; Dong S
Biochim Biophys Acta; 2014 Nov; 1839(11):1084-96. PubMed ID: 25123438
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP).
Chiu YH; Mensah KA; Schwarz EM; Ju Y; Takahata M; Feng C; McMahon LA; Hicks DG; Panepento B; Keng PC; Ritchlin CT
J Bone Miner Res; 2012 Jan; 27(1):79-92. PubMed ID: 21987375
[TBL] [Abstract][Full Text] [Related]
13. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP).
Kim K; Lee SH; Ha Kim J; Choi Y; Kim N
Mol Endocrinol; 2008 Jan; 22(1):176-85. PubMed ID: 17885208
[TBL] [Abstract][Full Text] [Related]
14. Effect of a rare genetic variant of TM7SF4 gene on osteoclasts of patients with Paget's disease of bone.
Laurier E; Amiable N; Gagnon E; Brown JP; Michou L
BMC Med Genet; 2017 Nov; 18(1):133. PubMed ID: 29145829
[TBL] [Abstract][Full Text] [Related]
15. Short-term mechanical stress inhibits osteoclastogenesis via suppression of DC-STAMP in RAW264.7 cells.
Kameyama S; Yoshimura Y; Kameyama T; Kikuiri T; Matsuno M; Deyama Y; Suzuki K; Iida J
Int J Mol Med; 2013 Feb; 31(2):292-8. PubMed ID: 23292096
[TBL] [Abstract][Full Text] [Related]
16. Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis.
Gross C; Weber M; Creutzburg K; Möbius P; Preidl R; Amann K; Wehrhan F
J Transl Med; 2017 Jun; 15(1):128. PubMed ID: 28587628
[TBL] [Abstract][Full Text] [Related]
17. Mechanical vibration inhibits osteoclast formation by reducing DC-STAMP receptor expression in osteoclast precursor cells.
Kulkarni RN; Voglewede PA; Liu D
Bone; 2013 Dec; 57(2):493-8. PubMed ID: 23994170
[TBL] [Abstract][Full Text] [Related]
18. Letrozole Suppresses the Fusion of Osteoclast Precursors through Inhibition of p38-Mediated DC-STAMP Pathway.
Kim HJ; Seong HS; Choi Y; Heo SC; Kim YD
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182361
[TBL] [Abstract][Full Text] [Related]
19. Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP.
Islam R; Bae HS; Yoon WJ; Woo KM; Baek JH; Kim HH; Uchida T; Ryoo HM
J Cell Physiol; 2014 Dec; 229(12):2166-74. PubMed ID: 24891219
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
